文献速递瓣膜外科

退行性二尖瓣修复术后早期与晚期失败再手术的机制与再修复耐久性

Reoperation after early and late failure of mitral valve repair for degenerative disease.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-09-27

本研究回顾2008年1月至2020年7月330例因退行性二尖瓣修复术后复发功能障碍而再手术的病例,分析早期(1年内)与晚期失败机制、再修复率及耐久性。早期失败以缝合/瓣环裂开、收缩期前向运动、溶血和心室重构更常见,晚期以疾病进展和纤维化为主。再修复在近期更常见且与更早再手术相关,再修复后7年免于重度二尖瓣反流为93%。

要点

  • 早期失败(85/330例,26%)以缝合/瓣环裂开、收缩期前向运动、溶血和心室重构更常见,晚期失败(245/330例,74%)以疾病进展和纤维化为主。
  • 早期失败再修复率40%(34/85)高于晚期失败24%(59/245),再修复较置换更常见于近年且与更早再手术相关(中位1.5 vs 3.9年;P = .0001)。
  • 再修复后无院内死亡,瓣膜置换后2例(0.8%)死亡;再修复后7年免于重度二尖瓣反流为93%。

核心结论

  • 退行性二尖瓣修复术后早期和晚期功能障碍均可再修复,死亡率和并发症率低;早期与晚期失败机制不同,早期失败通常更适合再修复。
  • 对于修复失败后就诊的特定患者,作者倾向于在技术可行时行二尖瓣再修复而非瓣膜置换。

研究设计与样本

  • 回顾性分析2008年1月至2020年7月330例因退行性二尖瓣修复术后复发功能障碍而再手术的病例。
  • 通过复习术前影像和手术记录确定修复失败机制,多变量分析识别与再修复或置换可能性相关的因素,纵向分析术后超声数据评估再修复耐久性。

主要发现

  • 330例再手术中,85例(26%)为1年内早期修复失败,245例(74%)为 thereafter 晚期失败。
  • 早期失败更常见的机制为缝合/瓣环裂开、收缩期前向运动、溶血和心室重构,晚期失败更常见的机制为疾病进展和纤维化。
  • 早期失败再修复率为40%(34/85),晚期失败为24%(59/245)。
  • 再修复较置换更常见于近年,且与更早再手术相关(中位1.5 vs 3.9年;P = .0001)。
  • 再修复后无院内死亡,瓣膜置换后2例(0.8%)死亡;再修复后7年免于重度二尖瓣反流为93%。

关键数值与推荐

  • 早期失败再修复率40%(34/85)vs 晚期失败24%(59/245)。
  • 再修复与更早再手术相关(中位1.5 vs 3.9年;P = .0001)。
  • 再修复后7年免于重度二尖瓣反流为93%。

临床怎么用

  • 作者认为,对于修复失败后就诊的特定患者,只要技术可行,倾向于行二尖瓣再修复而非瓣膜置换。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine mechanisms of early and late failure after mitral valve repair for degenerative disease, identify factors associated with re-repair, and evaluate durability of re-repair. METHODS: From January 2008 to July 2020, 330 reoperations were performed for recurrent mitral valve dysfunction after initial valve repair for degenerative disease. Mechanisms of repair failure were determined by review of preoperative imaging and operative reports. Multivariable analysis was performed to identify factors associated with likelihood of re-repair or replacement. Durability of re-repair was assessed using longitudinal analysis of postoperative echo data. RESULTS: Eighty-five of 330 (26%) reoperations were performed for early repair failure within 1 year and 245/330 (74%) for late failure thereafter. Suture/annuloplasty dehiscence, systolic anterior motion, hemolysis, and ventricular remodeling were more common mechanisms of early failure and disease progression and fibrosis late failure. Forty percent (34/85) of early failures were re-repaired versus 24% (59/245) of late failures. Re-repair was more common than replacement in recent years and was associated with earlier reoperation (median 1.5 vs 3.9 years; P = .0001). No in-hospital deaths occurred after re-repair; 2 patients (0.8%) died after valve replacement. Freedom from severe mitral regurgitation after re-repair was 93% at 7 years. CONCLUSIONS: Mitral valve re-repair can be performed with low rates of mortality and morbidity for early and late valve dysfunction. Mechanisms of early repair failure differ from those of late failure and are generally more amenable to re-repair. In selected patients who present after failed repair, we prefer mitral re-repair to valve replacement whenever technically feasible.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Moore RA, Wierup P, Tappuni S, et al. Reoperation after early and late failure of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 2022. PMID: 36323616. doi:10.1016/j.jtcvs.2022.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。